Gabelli & CO Investment Advisers, Inc. Vertex Pharmaceuticals Inc Transaction History

Gabelli & CO Investment Advisers, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$283.23 - $323.1 $198,261 - $226,170	700 New	700 $220,000
Q1 2022 May 13, 2022	SELL	$221.42 - $260.97 $254,633 - $300,115	-1,150 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$177.01 - $223.45 $12,921 - $16,311	-73 Reduced 5.97%	1,150 $253,000
Q3 2021 Nov 12, 2021	BUY	$181.39 - $202.99 $27,208 - $30,448	150 Added 13.98%	1,223 $222,000
Q2 2021 Aug 13, 2021	BUY	$187.49 - $221.1 $201,176 - $237,240	1,073 New	1,073 $216,000

1,723

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Gabelli & CO Investment Advisers, Inc., based on Form 13F filings with the SEC.

Stay updated on Gabelli & CO Investment Advisers, Inc. with notifications on news.